semaglutide oral obesity Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Everything You Need To Know

She adds another explanation for why some individuals might seem to observe this association: Weight gain is also linked to the perimenopausal and post-menopausal state, and a GLP-1 is a reasonable treatment for this for those who qualify. What this means is that for some women, the weight loss effects of a GLP-1 and the symptoms of low estrogen may occur at the same time, making it difficult to tell whether the changes are due to the medication, hormonal shifts, or both

This adds to the findings of the current selection of available studies that show a similar risk of retained gastric contents among users of GLP-1RA

Oral mucosal nevi have a slight female predominance (1.5:1 female-to-male ratio), except for blue nevi, which occur with equal frequency in males and females

Pinealon acts as a biological regulator that apparently protects the brain

Tirzepatide in type 1 diabetes: single-centre observational cohort (N=26), 2025

Anabolic steroids generally produce faster and more direct increases in muscle size and strength because they activate androgen receptors and increase anabolic activity